Primary results of mechanical thrombectomy for acute ischemic stroke: The K-NET registry in the Japanese metropolitan area

Author:

Ueda Toshihiro1ORCID,Hasegawa Yasuhiro2,Takeuchi Masataka3,Morimoto Masafumi4,Tsuboi Yoshifumi5,Yamamoto Ryoo6,Kaku Shogo7,Ayabe Junichi8,Akiyama Takekazu9,Ishima Daisuke10,Mori Kentaro11,Kagami Hiroshi12,Ito Hidemichi2,Onodera Hidetaka13,Doi Hiroshi14,Tsumoto Tomoyuki15,Hataoka Shunsuke16,Noda Masayuki17,Tomura Nagatsuki18,Masuo Osamu19,Yoshida Yoichi20,Kaga Yasuyuki2,Tatsuno Kentaro1,Yoshie Tomohide1,Takaishi Satoshi1,Yamano Yoshihisa2ORCID,

Affiliation:

1. Department of Strokology and Neuroendovascular Therapy, Stroke Center, St. Marianna University Toyoko Hospital, Kawasaki, Japan

2. St. Marianna University School of Medicine, Kawasaki, Japan

3. Seisho Hospital, Odawara, Japan

4. Yokohama Shintoshi Neurosurgical Hospital, Yokohama, Japan

5. Kawasaki Saiwai Hospital, Kawasaki, Japan

6. Yokohama Brain and Spine Center, Yokohama, Japan

7. Neurosurgical East Yokohama Hospital, Yokohama, Japan

8. Yokosuka Kyosai Hospital, Yokosuka, Japan

9. Akiyama Neurosurgical Hospital, Yokohama, Japan

10. Kitasato University Hospital, Sagamihara, Japan

11. Yokohama Sakae Kyosai Hospital, Yokohama, Japan

12. Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan

13. St. Marianna University Yokohama Seibu Hospital, Yokohama, Japan

14. Yokohama City University Graduate School of Medicine, Yokohama, Japan

15. Showa University Fujigaoka Hospital, Yokohama, Japan

16. National Hospital Organization, Yokohama Medical Center, Yokohama, Japan

17. Yokohama Shinmidori General Hospital, Yokohama, Japan

18. Yokohama Rosai Hospital, Yokohama, Japan

19. Yokohama Municipal Citizen’s Hospital, Yokohama, Japan

20. Yokohama Asahi Chuo General Hospital, Yokohama, Japan

Abstract

Background: Endovascular treatment (EVT) for acute large vessel occlusion has proven to be effective in randomized controlled trials. We conducted a prospective cohort study to evaluate the real-world efficacy of EVT in a metropolitan area with a large number of comprehensive stroke centers and to compare it with the results of other registries and randomized controlled trials (RCTs). Methods: We analyzed the Kanagawa Intravenous and Endovascular Treatment of Acute Ischemic Stroke registry, a prospective, multicenter observational study of patients treated by EVT and/or intravenous tissue-type plasminogen activator (tPA). Of the 2488 patients enrolled from January 2018 to June 2020, 1764 patients treated with EVT were included. The primary outcome was a good outcome, which was defined as a modified Rankin Scale (mRS) of 0–2 at 90 days. Secondary analysis included predicting a good outcome using multivariate logistic regression analysis. Results: The median age was 77 years, and the median National Institute of Health Stroke Scale (NIHSS) score was 18. Pretreatment mRS score 0–2 was 87%, and direct transport was 92%. The rate of occlusion in anterior circulation was 90.3%. Successful recanalization was observed in 88.7%. The median time from onset to recanalization was 193 min. Good outcomes at 90 days were 43.3% in anterior circulation and 41.9% in posterior circulation. Overall mortality was 12.6%. Significant predictors for a good outcome were as follows: age, male, direct transfer, NIHSS score, Alberta Stroke Program Early Computed Tomography Score, intravenous tPA, and successful recanalization. Conclusion: EVT in routine clinical use in a metropolitan area showed comparable good outcomes and lower mortality compared to previous studies, despite the high proportion of patients with older age, pretreatment mRS score of >2, posterior circulation occlusion, and higher NIHSS. Those results may have been associated with more direct transport and faster onset-to-recanalization times.

Funder

a grant from the Japanese Society of Neuroendovascular Therapy

Publisher

SAGE Publications

Subject

Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3